Lisa Ray Highlights Chemotherapy-Induced Early Menopause and Fertility Challenges

ଶିକ୍ଷା

Telangana State Board of Intermediate Education TS Class...

April 10, 2026

57% Gen Z ଉଚ୍ଚ ଦରମା ଚାହୁଁଛନ୍ତି: ଦକ୍ଷତା ଆଧାରିତ...

April 10, 2026

Board of Secondary Education Assam HSLC 10ମ ଫଳାଫଳ...

April 10, 2026

ପୁସ୍ତକ ଦରକାର କାହାକୁ? CBSEର 3 ଭାଷା ନୀତିର 3ଟି...

April 10, 2026

ରାଜନୀତି

ବିହାର ମୁଖ୍ୟମନ୍ତ୍ରୀ Nitish Kumarଙ୍କ ଜାତୀୟ ରାଜନୀତିରେ ପ୍ରବେଶ, ଶୀଘ୍ର...

April 10, 2026

Sasmit Patra ରାଜ୍ୟସଭାରେ BJD ନେତା ପଦରୁ ପଦତ୍ୟାଗ, ଦଳଭିତ୍ତିକ...

April 09, 2026

ବାରାମତୀ ଉପନିର୍ବାଚନରେ ଏକମାତ୍ର ପ୍ରାର୍ଥୀ: କଂଗ୍ରେସ ପଛହଟିବା ପରେ ସୁନେତ୍ରା...

April 09, 2026

West Bengal ନିର୍ବାଚନ: ଭୟମୁକ୍ତ ଓ ହିଂସାମୁକ୍ତ ଭୋଟିଂ ପାଇଁ...

April 08, 2026

Lisa Ray Highlights Chemotherapy-Induced Early Menopause and Fertility Challenges

Actor Lisa Ray revealed that chemotherapy pushed her into early menopause at 37, shedding light on fertility and hormonal issues many young cancer survivors face. Experts stress early counselling and fertility preservation strategies are crucial before treatment begins.

Published by Somesh | February 18, 2026

Actor Lisa Ray’s revelation that chemotherapy induced early menopause at the age of 37 has sparked a vital conversation on an often-overlooked aspect of cancer treatment. Diagnosed with multiple myeloma in 2009, Ray spoke about the emotional and physical challenges of losing fertility and experiencing menopause unexpectedly, highlighting a gap in survivorship care.

Medical experts explain that chemotherapy, while targeting rapidly dividing cancer cells, can also damage ovarian cells, reduce egg reserves, and in some cases trigger temporary or permanent menopause. Women over 35–40, those undergoing longer treatment durations, or receiving certain drugs like alkylating agents are at higher risk.

Fortunately, protective strategies exist if discussed early. Fertility preservation options include egg or embryo freezing, ovarian tissue freezing, and the use of GnRH analogues to temporarily suppress ovarian function during chemotherapy. In cases where pelvic radiation is planned, ovarian transposition may also be considered. While no method guarantees prevention, early planning significantly improves outcomes.

Chemotherapy-induced menopause, often called “chemopause,” remains under-discussed. During diagnosis, the primary focus is survival, and reproductive or hormonal concerns may feel secondary. Social stigma around discussing reproductive health further contributes to the lack of awareness.

Hormone replacement therapy (HRT) can alleviate menopausal symptoms and protect bone and cardiovascular health but must be individualized. In hormone-sensitive cancers, HRT is generally avoided, while survivors without hormone-driven cancers may consider it under medical guidance.

Ray’s candid disclosure underscores that surviving cancer involves more than treatment success. Informed discussions about fertility, symptom management, and long-term hormonal health are essential for improving the quality of life for women undergoing chemotherapy.